Team finds method to reduce accumulation of damaging Huntington's disease protein

A study appearing April 14 in the journal Neuron suggests there may be a new way to change the damaging course of Huntington disease.

University of California, Irvine neurobiologists Leslie Thompson and Joseph Ochaba with the Departments of Neurobiology & Behavior and Psychiatry & Human Behavior and their colleagues from UCI and from Children's Hospital of Philadelphia have shown that reducing the aberrant accumulation of a particular form of the mutant Huntingtin protein corresponds to improvement in symptoms and neuroinflammation in HD mice.

They showed this by targeting and modulating levels of PIAS1 - a protein implicated in cancer and other diseases - which they found led to the reduction of the mutant Huntington protein.

The work suggests that changing levels of the PIAS1 protein and targeting this pathway could have a benefit to disease.

There are no current treatments for HD, although Thompson's ongoing work with stem cell-based therapies are showing promise.

Explore further

Study demonstrates how Huntington's disease proteins spread from cell to cell

More information: Joseph Ochaba et al. PIAS1 Regulates Mutant Huntingtin Accumulation and Huntington's Disease-Associated Phenotypes In Vivo, Neuron (2016). DOI: 10.1016/j.neuron.2016.03.016
Journal information: Neuron

Citation: Team finds method to reduce accumulation of damaging Huntington's disease protein (2016, April 15) retrieved 6 April 2020 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments